ACTIVE

Dr. Isabelle RAVELINGIEN – REUMATOLOGE

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result197,7 k €-7,2 %over 1 year
Gross margin275,4 k €+1,7 %over 1 year
Equity971,3 k €+9,1 %over 1 year

Identity

Source · BCE/KBO

Dr. Isabelle RAVELINGIEN – REUMATOLOGE is a Private limited company incorporated in 2011. Its registered office is in Lennik.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0837.431.682
Incorporation
30/06/2011
Legal form
Private limited company
Registered office
Schapenstraat 82
1750 Lennik · FlandreSee on map
Contributed capital
12 400,00 €
Latest accounts
30/06/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 14 filings

Trend over 13 financial years

20252024202320222021
Income statement
Gross margin275,4 k €270,9 k €189,1 k €245 k €251,8 k €
EBITDA273,8 k €269,2 k €187,5 k €243,6 k €251,2 k €
Operating result271,8 k €267,3 k €186,8 k €243,1 k €228,4 k €
Net result197,7 k €213,1 k €134,5 k €143,7 k €156,6 k €
Balance sheet
Equity971,3 k €890,3 k €820,5 k €685,9 k €888 k €
Total assets1 M €919,5 k €1 M €1 M €975,2 k €
Cash838,6 k €264,4 k €820,1 k €723,2 k €861,3 k €
Debts77,7 k €28,9 k €201,1 k €317,7 k €85,7 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Isabelle Ravelingien
Directorsince 28/06/2011Administrator - managerendedManagerended

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date29/12/202518/12/202414/12/202302/01/202328/04/202223/02/2021
General meeting28/11/202529/11/202424/11/202325/11/202225/02/202227/11/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 14 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/06/202528/11/202529/12/2025DutchPDF
Micro model30/06/202429/11/202418/12/2024DutchPDF
Micro model30/06/202324/11/202314/12/2023DutchPDF
Micro model30/06/202225/11/202202/01/2023DutchPDF
Micro model30/06/202125/02/202228/04/2022DutchPDF
Micro model30/06/202027/11/202023/02/2021DutchPDF
Micro model30/06/201929/11/201930/01/2020DutchPDF
Micro model30/06/201830/11/201811/01/2019DutchPDF
Micro model30/06/201724/11/201728/11/2017DutchPDF
Abridged model30/06/201625/11/201606/12/2016DutchPDF
Abridged model30/06/201527/11/201518/12/2015DutchPDF
Abridged model30/06/201428/11/201401/12/2014DutchPDF
Abridged model30/06/201329/11/201320/12/2013DutchPDF
Abridged model30/06/201221/12/201207/01/2013DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Isabelle Ravelingien
Directorsince 28/06/2011Administrator - managerendedManagerended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates28/12/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - DOEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares30/01/2012
    KAPITAAL - AANDELEN
    PDF
  • Registered office29/12/2011
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other12/07/2011
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings13 filings
Mandates
Isabelle Ravelingien
2011201220132014201520162017201820192020202120222023202420252026
Dr. Isabelle RAVELINGIEN – REUMATOLOGE
Schapenstraat 82, 1750 Lennik
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Schapenstraat 82, 1750 LennikCurrent
accounts 2021 → 2025
Accounts 2025 · 2025-00591261

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Dr. Isabelle RAVELINGIEN – REUMATOLOGECurrent
accounts 2021 → 2025
Accounts 2025 · 2025-00591261

Events

  1. 2025
    Annual accounts 2025197,7 k €↓
  2. 2024
    Annual accounts 2024213,1 k €↑
  3. 2023
    Annual accounts 2023134,5 k €↓
  4. 2022
    Annual accounts 2022143,7 k €↓
  5. 2021
    Annual accounts 2021156,6 k €↑
  6. 2019
    Annual accounts 2019116,7 k €↑
  7. 2018
    Annual accounts 201854,1 k €↓
  8. 2017
    Annual accounts 201789,2 k €↓
  9. 2016
    Annual accounts 201697,9 k €↓
  10. 2015
    Annual accounts 2015106,8 k €↓
  11. 2014
    Annual accounts 2014141,1 k €↑
  12. 2013
    Annual accounts 201399,1 k €↑
  13. 2012
    Annual accounts 201266,5 k €
  14. 30/06/2011
    IncorporationPrivate limited company